Altshuler Shaham LTD Fibrogen Inc Transaction History

Altshuler Shaham LTD

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 09, 2023	SELL	$15.95 - $25.18 $27,465 - $43,359	-1,722 Closed	0 $0
Q4 2022 May 09, 2023	BUY	$13.27 - $17.73 $22,850 - $30,531	1,722 New	1,722 $27,000
Q3 2021 Nov 15, 2021	SELL	$10.18 - $26.64 $3 Million - $7.86 Million	-295,086 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$18.57 - $35.68 $5.48 Million - $10.5 Million	295,086 New	295,086 $7.86 Million
Q4 2018 Feb 11, 2019	SELL	$37.97 - $60.16 $368,005 - $583,070	-9,692 Closed	0 $0
Q3 2018 Nov 13, 2018	SELL	$56.3 - $67.25 $545,603 - $651,719	-9,691 Reduced 50.0%	9,692 $589,000
Q2 2018 Aug 13, 2018	BUY	$44.9 - $64.95 $390,630 - $565,065	8,700 Added 81.44%	19,383 $1.21 Million
Q1 2018 May 15, 2018	SELL	$45.35 - $61.65 $52,923 - $71,945	-1,167 Reduced 9.85%	10,683 $494,000
Q4 2017 May 14, 2018	BUY	$41.95 - $60.1 $497,107 - $712,185	11,850	11,850 $562,000

47.1M

387K

672K

Ticker FGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,741,200
Market Cap $32.8M
Description
FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...

Get notified when there are updates to the investment portfolio of Altshuler Shaham LTD, based on Form 13F filings with the SEC.

Stay updated on Altshuler Shaham LTD with notifications on news.